Literature DB >> 7625888

Elevated levels of nerve growth factor in the thalamus and spinal cord of rats affected by experimental allergic encephalomyelitis.

A Micera1, R De Simone, L Aloe.   

Abstract

In a previous study it was shown that the levels of NGF in the cerebrospinal fluid of patients affected by multiple sclerosis (MS) increase during the acute phase of the disease and decrease in the remission phase. In the present study, using an animal model of MS, we investigate whether any changes in NGF levels occur in brains of rats affected by Experimental Allergic Encephalomyelitis (EAE). The results show an enhanced level of NGF in the thalamus and spinal cord and a numerical increase of mast cells (MCs) expressing mRNA-NGF localized in these two regions. These observations suggest that NGF is involved in EAE and that MCs contribute to the local increase of NGF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625888

Source DB:  PubMed          Journal:  Arch Ital Biol        ISSN: 0003-9829            Impact factor:   1.000


  6 in total

1.  Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.

Authors:  Nina Wagenknecht; Birte Becker; Miriam Scheld; Cordian Beyer; Tim Clarner; Tanja Hochstrasser; Markus Kipp
Journal:  J Mol Neurosci       Date:  2016-08-04       Impact factor: 3.444

Review 2.  Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis.

Authors:  A Rouleau; V Dimitriadou; M D Trung Tuong; G F Newlands; H R Miller; J C Schwartz; M Garbarg
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis.

Authors:  L Calzà; L Giardino; M Pozza; A Micera; L Aloe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

Review 4.  Thalamus pathology in multiple sclerosis: from biology to clinical application.

Authors:  Markus Kipp; Nina Wagenknecht; Cordian Beyer; Sebastian Samer; Jens Wuerfel; Omid Nikoubashman
Journal:  Cell Mol Life Sci       Date:  2014-11-23       Impact factor: 9.261

5.  Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.

Authors:  Orhan Tansel Korkmaz; Neşe Tunçel; Muzaffer Tunçel; Elif Mine Oncü; Varol Sahintürk; Mustafa Celik
Journal:  J Mol Neurosci       Date:  2009-12-02       Impact factor: 3.444

Review 6.  Surprising pleiotropy of nerve growth factor in the treatment of experimental autoimmune encephalomyelitis.

Authors:  R M Ransohoff; C Trebst
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.